Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jiro Tanaka

Jiro Tanaka, Okayama JP

Patent application numberDescriptionPublished
20080200630Medical Resin Composition, Process For Producing Resin Composition and Process For Producing Molded Article - A medical resin composition is produced by mixing a powder of a polymer (A) comprising repeating units having an ester group and a liquid of a vinyl ester monomer (B) having 6 or more carbon atoms to increase a viscosity and, according to demand, further performing a polymerization reaction. The thus produced resin composition inhibits leaching of irritative substances, reduces any adverse effects on the human body by endocrine disruptors, etc. and can be prepared with high operational efficiency. The resin composition is suitably used as a dental resin composition such as a tissue conditioner, a functional impression material, a lining material, a denture base material or a mouth piece material. 08-21-2008
20090053948BASE FOR SYNTHETIC LEATHER AND SYNTHETIC LEATHERS MADE BY USING THE SAME - A substrate for artificial leathers, comprising a nonwoven fabric body made of microfine fiber bundles and an elastic polymer impregnated therein. The substrate for artificial leathers simultaneously satisfies the following requirements 1 to 4: (1) each of the microfine fiber bundles contains 6 to 150 bundled microfine long fibers in average; (2) a cross-sectional area of the microfine long fibers constituting the microfine fiber bundles is 27 μm02-26-2009
20090087618BASE MATERIAL FOR ARTIFICIAL LEATHERS AND METHOD OF PRODUCING THE SAME - A substrate for artificial leathers which is composed of a nonwoven fabric made of fiber bundles of microfine fibers having an average single fiber fineness of 0.5 dtex or less and an elastic polymer impregnated into the nonwoven fabric. The substrate for artificial leathers satisfies the following requirements 1 and 2: (1) the number of fiber bundles which are oriented to a thickness direction of the nonwoven fabric is 75 to 300 per 1 cm of width which is perpendicular to the thickness direction, when measured on a cross section parallel to the thickness direction; and (2) the number of cross sections of the fiber bundles which are oriented to the thickness direction is 30 to 800 per 1 mm04-02-2009
20090124156BASE MATERIAL FOR ARTIFICIAL LEATHER AND GRAINED ARTIFICIAL LEATHER - A substrate for artificial leathers composed of an entangled nonwoven fabric made of microfine fibers and a binder resin. At least one surface of the substrate for artificial leathers is a densified layer which is made of the microfine fibers and which is substantially free from the binder resin. The binder resin is impregnated into a portion of the substrate for artificial leathers other than the densified layer. The densified layer prevents the binder resin impregnated into the entangled nonwoven fabric from migrating into the surface of the entangled nonwoven fabric, thereby providing the substrate for artificial leathers having the surface substantially free from the binder resin. The peeling strength between the substrate for artificial leathers and a grain layer formed on the surface thereof is drastically improved because the surface of the substrate for artificial leathers is substantially free from the binder resin.05-14-2009
20090274862Leather-Like Sheet And Method Of Manufacturing The Same - A leather-like sheet composed of a microfine-fiber entangled body made of bundles of microfine fibers and an elastic polymer impregnated therein. The bundles of microfine fibers are composed of microfine monofibers having an average cross-sectional area of 0.1 to 30 μm11-05-2009
20100086738LEATHER-LIKE SHEET BEARING GRAIN FINISH AND PROCESS FOR PRODUCING THE SAME - A (semi)grain-finished leather-like sheet composed of an entangled nonwoven fabric of three-dimensionally entangled fiber bundles containing microfine long fibers and an elastic polymer contained in the entangled nonwoven fabric. When dividing the (semi)grain-finished leather-like sheet to five layers with equal thickness, i.e., surface layer, substrate layer 04-08-2010
20100159771BASE MATERIAL FOR ARTIFICIAL LEATHER AND METHOD OF PRODUCING THE SAME - A substrate for artificial leathers which is composed of a united laminate of a nonwoven fabric layer A made of bundles of microfine fibers having an average single fiber fineness of 0.5 dtex or less and a cushion layer B made of an elastic polymer sheet. A part of the microfine fibers constituting the nonwoven fabric layer A is allowed to penetrate through the cushion layer B to form a microfine fiber layer C on the outer surface of the cushion layer B. The inner surface of the elastic polymer sheet is undulated with a height difference of 100 μm or more in a thickness direction. Between the undulated surface of the elastic polymer sheet and the nonwoven fabric layer A, voids having a height of 100 μm or more in a thickness direction are formed. Using the substrate for artificial leathers, grain-finished artificial leathers which combine a softness without resistance and a stiff hand resembling natural sheep leathers and have bent wrinkles with fullness are produced.06-24-2010
20110039055BASE MATERIAL FOR ARTIFICIAL LEATHER AND PROCESS FOR PRODUCING THE SAME - A substrate for artificial leather comprising a nonwoven fabric of bundles of microfine filaments. The substrate for artificial leather simultaneously satisfies the following requirements 1 to 4: (1) the bundle of microfine filaments comprises 8 to 70 microfine filaments having a cross-sectional shape of nearly circle; (2) the bundle of microfine filaments has a cross-sectional area of 170 to 700 μm02-17-2011

Patent applications by Jiro Tanaka, Okayama JP

Jiro Tanaka, Kanagawa JP

Patent application numberDescriptionPublished
20100330100PSEUDOMONAS AERUGINOSA-OUTER MEMBRANE PROTEIN PA4710 - An object is to provide: a protein antigen or a peptide antigen usable as a vaccine composition which has an ability to practically prevent or treat a 12-30-2010

Jiro Tanaka, Chuo-Ku JP

Patent application numberDescriptionPublished
20100291070TYPE III SECRETION SYSTEM COMPONENT PROTEIN PA1698 OF PSEUDOMONAS AERUGINOSA - An object is to provide an antibody and a vaccine composition which have an ability to practically prevent or treat a 11-18-2010

Jiro Tanaka, Okayama-Shi JP

Patent application numberDescriptionPublished
20100087128POLISHING PAD, AND METHOD FOR MANUFACTURING POLISHING PAD - It is an object of the present invention to provide a polishing pad that is resistant to scratching and also has excellent flattening performance. One aspect of the present invention is a polishing pad, comprising a fiber-entangled body formed from fiber bundles made up of ultrafine fibers in which the average cross sectional area is between 0.01 and 30 μm04-08-2010
20100184921Process for producing resin composition and process for producing molded article - A medical resin composition is produced by mixing a powder of a polymer (A) comprising repeating units having an ester group and a liquid of a vinyl ester monomer (B) having 6 or more carbon atoms to increase a viscosity and, according to demand, further performing a polymerization reaction. The thus produced resin composition inhibits leaching of irritative substances, reduces any adverse effects on the human body by endocrine disruptors, etc. and can be prepared with high operational efficiency. The resin composition is suitably used as a dental resin composition such as a tissue conditioner, a functional impression material, a lining material, a denture base material or a mouth piece material.07-22-2010

Jiro Tanaka, Kanagawa-Ken JP

Patent application numberDescriptionPublished
20090117121Pseudomonas Aeruginosa Outer Membrane Protein PA0427 - An object of the present invention is to provide a protein or peptide antigen and an antibody against it, for use in the diagnosis, prevention, or treatment of diseases associated with 05-07-2009
20090155279Pseudomonas Aeruginosa Outer Membrane Protein PA5158 - An object of the present invention is to provide a protein or peptide antigen and an antibody against it, for use in the diagnosis, prevention, or treatment of diseases associated with 06-18-2009